Targeted sequencing of selected functional genes in patients with wild-type transthyretin amyloidosis

被引:0
|
作者
Moreno-Gazquez, Inmaculada [1 ,7 ]
Perez-Palacios, Raquel [2 ,7 ]
Abengochea-Quilez, Lucia [3 ,6 ,7 ]
Lahuerta Pueyo, Carmen [1 ,7 ]
Roteta Unceta Barrenechea, Ana [4 ,7 ]
Andres Gracia, Alejandro [4 ,7 ]
Aibar Arregui, Miguel Angel [5 ,7 ]
Menao Guillen, Sebastian [1 ,7 ]
机构
[1] Hosp Clin Univ Lozano Blesa, Dept Clin Biochem, Zaragoza, Spain
[2] Univ Zaragoza, Vet Fac, Dept Anat Embryol & Genet, Zaragoza, Spain
[3] Hlth Res Inst Aragon, Zaragoza, Spain
[4] Multihosp Nucl Med Clin Unit Aragon, Dept Nucl Med, Zaragoza, Spain
[5] Hosp Clin Univ Lozano Blesa, Dept Internal Med, Zaragoza, Spain
[6] Univ Zaragoza, Dept Chem & Environm Engn, Campus Rio Ebro Edificio I D, Zaragoza, Spain
[7] GIIS 084 IIS Aragon, Basic Res Internal Med Grp, Zaragoza, Spain
关键词
ATTRwt amyloidosis; Gene variants; Targeted sequencing; Transthyretin amyloidosis; A-BETA; POLYNEUROPATHY; MUTATIONS; VARIANTS; DISEASE; BINDING; AGE;
D O I
10.1186/s13104-023-06491-z
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
ObjectiveWild-type transthyretin (ATTRwt) amyloidosis is caused by the misfolding and deposition of the transthyretin protein (TTR) in the absence of mutations in the TTR gene. Studies regarding the variant form of ATTR amyloidosis (ATTRv) suggest that the presence of single-nucleotide polymorphisms (SNP) in genes other than the TTR, may influence the development of the disease. However, other genetic factors involved in the aetiopathogenesis of ATTRwt are currently unknown. This work investigates the presence of sequence variants in genes selected for their possible impact on ATTRwt amyloidosis. To do so, targeted sequencing of 84 protein-coding genes was performed in a cohort of 27 patients diagnosed with ATTRwt.ResultsAfter applying quality and frequency filtering criteria, 72 rare or novel genetic variants were found. Subsequent classification according to the ACMG-AMP criteria resulted in 17 variants classified as of uncertain significance in 14 different genes. To our knowledge, this is the first report associating novel gene variants with ATTRwt amyloidosis. In conclusion, this study provides potential insights into the aetiopathogenesis of ATTRwt amyloidosis by linking novel coding-gene variants with the occurrence of the disease.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Tafamidis: a selective transthyretin stabilizer to treat wild-type ATTR amyloidosis and hereditary ATTR amyloidosis with cardiomyopathy
    Paton, D. M.
    DRUGS OF TODAY, 2019, 55 (12) : 727 - 734
  • [22] Personalized medicine approach for optimizing the dose of tafamidis to potentially ameliorate wild-type transthyretin amyloidosis (cardiomyopathy)
    Cho, Younhee
    Baranczak, Aleksandra
    Helmke, Stephen
    Teruya, Sergio
    Horn, Evelyn M.
    Maurer, Mathew S.
    Kelly, Jeffery W.
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2015, 22 (03): : 175 - 180
  • [23] Sex-related differences in the clinical characteristics of wild-type transthyretin amyloidosis cardiomyopathy
    Takashio, Seiji
    Yamada, Toshihiro
    Nishi, Masato
    Morioka, Mami
    Fujiyama, Akira
    Nakashima, Naoya
    Hirakawa, Kyoko
    Hanatani, Shinsuke
    Usuku, Hiroki
    Yamamoto, Eiichiro
    Ueda, Mitsuharu
    Matsushita, Kenichi
    Tsujita, Kenichi
    JOURNAL OF CARDIOLOGY, 2022, 79 (01) : 50 - 57
  • [24] Predictors of survival stratification in patients with wild-type cardiac amyloidosis
    Siepen, F. Aus Dem
    Bauer, R.
    Voss, A.
    Hein, S.
    Aurich, M.
    Riffel, J.
    Mereles, D.
    Roecken, C.
    Buss, S. J.
    Katus, H. A.
    Kristen, Arnt V.
    CLINICAL RESEARCH IN CARDIOLOGY, 2018, 107 (02) : 158 - 169
  • [25] Peripheral neuropathy symptoms in wild type transthyretin amyloidosis
    Wajnsztajn Yungher, Fernanda
    Kim, Arreum
    Boehme, Amelia
    Kleyman, Inna
    Weimer, Louis H.
    Maurer, Mathew S.
    Brannagan, Thomas H., III
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2020, 25 (03) : 265 - 272
  • [26] Natural History of Wild-Type Transthyretin Cardiac Amyloidosis and Risk Stratification Using a Novel Staging System
    Grogan, Martha
    Scott, Christopher G.
    Kyle, Robert A.
    Zeldenrust, Steven R.
    Gertz, Morie A.
    Lin, Grace
    Klarich, Kyle W.
    Miller, Wayne L.
    Maleszewski, Joseph J.
    Dispenzieri, Angela
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (10) : 1014 - 1020
  • [27] Pressure-Volume Relationships in Patients With Transthyretin (ATTR) Cardiac Amyloidosis Secondary to V122I Mutations and Wild-Type Transthyretin Transthyretin Cardiac Amyloid Study (TRACS)
    Bhuiyan, Taslima
    Helmke, Stephen
    Patel, Ayan R.
    Ruberg, Frederick L.
    Packman, Jeff
    Cheung, Kin
    Grogan, Donna
    Maurer, Mathew S.
    CIRCULATION-HEART FAILURE, 2011, 4 (02) : 121 - 128
  • [28] Outcomes After Cardiac Transplant for Wild Type Transthyretin Amyloidosis
    Rosenbaum, Andrew N.
    AbouEzzeddine, Omar F.
    Grogan, Martha
    Dispenzieri, Angela
    Kushwaha, Sudhir
    Clavell, Alfredo
    Daly, Richard C.
    Edwards, Brooks S.
    TRANSPLANTATION, 2018, 102 (11) : 1909 - 1913
  • [29] Contribution of wild-type transthyretin to hereditary peripheral nerve amyloid
    Yazaki, M
    Liepnieks, JJ
    Kincaid, JC
    Benson, MD
    MUSCLE & NERVE, 2003, 28 (04) : 438 - 442
  • [30] Deep phenotyping of p.(V142I)-associated variant transthyretin amyloid cardiomyopathy: Distinct from wild-type transthyretin amyloidosis?
    Razvi, Yousuf
    Ioannou, Adam
    Patel, Rishi K.
    Chacko, Liza
    Karia, Nina
    Riefolo, Mattia
    Porcari, Aldostefano
    Rauf, Muhammad Umaid
    Starr, Neasa
    Ganesananthan, Sashiananthan
    Blakeney, Iona
    Kaza, Nandita
    Filisetti, Stefano
    Bolhuis, Roos Eline
    Rowczenio, Dorota
    Gilbertson, Janet
    Hutt, David
    Mahmood, Shameem
    Lachmann, Helen J.
    Wechalekar, Ashutosh D.
    Kotecha, Tushar
    Knight, Daniel S.
    Coghlan, John G.
    Petrie, Aviva
    Whelan, Carol J.
    Venneri, Lucia
    Martinez-Naharro, Ana
    Hawkins, Phillip
    Fontana, Marianna
    Gillmore, Julian D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2024, 26 (02) : 383 - 393